<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NHO</journal-id>
<journal-id journal-id-type="hwp">spnho</journal-id>
<journal-title>The Neurohospitalist</journal-title>
<issn pub-type="ppub">1941-8744</issn>
<issn pub-type="epub">1941-8752</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1941874413476044</article-id>
<article-id pub-id-type="publisher-id">10.1177_1941874413476044</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Images in Clinical Neurology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Reversible Corpus Callosum Splenium Lesion Associated With Hypoglycemic Encephalopathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Malik</surname>
<given-names>Amer M.</given-names>
</name>
<degrees>MD, MBA</degrees>
<xref ref-type="aff" rid="aff1-1941874413476044">1</xref>
<xref ref-type="corresp" rid="corresp1-1941874413476044"/>
</contrib>
<aff id="aff1-1941874413476044"><label>1</label>Swedish Neuroscience Institute, Swedish Medical Center, Seattle, WA, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1941874413476044">Amer M. Malik, Swedish Neuroscience Institute, 550 17th Avenue, James Tower, Suite 500, Seattle, WA 98122, USA. Email: <email>amermalik78@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>3</volume>
<issue>3</issue>
<fpage>169</fpage>
<lpage>169</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<kwd-group>
<kwd>splenium of corpus callosum</kwd>
<kwd>encephalopathy</kwd>
<kwd>hypoglycemia </kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1941874413476044">
<title>Images Clinical History</title>
<p>A 53-year-old male awoke with bilateral upper and lower extremity ataxia, optical apraxia, and binocular visual disturbance described as images jumping off the TV screen, and mild encephalopathy. He presented to the emergency department, where blood glucose levels ranged from 32 to 51 mg/dL. Magnetic resonance imaging (MRI) of the brain showed diffusion-weighted imaging (DWI) restriction in the splenium of the corpus callosum with apparent diffusion coefficient (ADC) correlates when the glucose level was 46 mg/dL. He was admitted and started on D5NS intravenous drip until blood glucose levels normalized and stabilized. Repeat MRI of the brain 36 hours later showed resolution of the DWI lesion (<xref ref-type="fig" rid="fig1-1941874413476044">Figure 1</xref>). It is important to consider hypoglycemia in the differential diagnosis of reversible splenium of corpus callosum lesions.<sup><xref ref-type="bibr" rid="bibr1-1941874413476044">1</xref></sup>
<fig id="fig1-1941874413476044" position="float">
<label>Figure 1.</label>
<caption>
<p>A, Magnetic resonance imaging diffusion-weighted imaging (MRI DWI) showing diffusion restriction in splenium of corpus callosum (arrow) when patient was known to be hypoglycemic and exhibiting neurological symptoms. B, The MRI DWI showing resolution of diffusion restriction in splenium of corpus callosum after the patient’s hypoglycemia was treated and the neurological symptoms were resolved.</p>
</caption>
<graphic xlink:href="10.1177_1941874413476044-fig1.tif"/>
</fig>
</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1941874413476044">
<label>Declaration of Conflicting Interests</label>
<p>The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1941874413476044">
<label>Funding</label>
<p>The author received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1941874413476044">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
</person-group> <article-title>Reversible splenial abnormality in hypoglycemic encephalopathy</article-title>. <source>Neuroradiology</source>. <year>2007</year>;<volume>49</volume>(<issue>3</issue>):<fpage>217</fpage>–<lpage>222</lpage>. </citation>
</ref>
</ref-list>
</back>
</article>